ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
32 hedge funds and large institutions have $35.7M invested in Anthera Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
32
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.05M | |
| 2 | +$844K | |
| 3 | +$754K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$278K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$208K |
Top Sellers
| 1 | -$926K | |
| 2 | -$666K | |
| 3 | -$614K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$463K |
| 5 |
B
Bailard
Foster City,
California
|
-$265K |